143 related articles for article (PubMed ID: 16212621)
21. IL-15, a novel T cell growth factor that shares activities and receptor components with IL-2.
Giri JG; Anderson DM; Kumaki S; Park LS; Grabstein KH; Cosman D
J Leukoc Biol; 1995 May; 57(5):763-6. PubMed ID: 7759955
[TBL] [Abstract][Full Text] [Related]
22. IL-2 unresponsiveness in anergic CD4+ T cells is due to defective signaling through the common gamma-chain of the IL-2 receptor.
Grundström S; Dohlsten M; Sundstedt A
J Immunol; 2000 Feb; 164(3):1175-84. PubMed ID: 10640728
[TBL] [Abstract][Full Text] [Related]
23. Blocking the common gamma-chain of cytokine receptors induces T cell apoptosis and long-term islet allograft survival.
Li XC; Ima A; Li Y; Zheng XX; Malek TR; Strom TB
J Immunol; 2000 Feb; 164(3):1193-9. PubMed ID: 10640730
[TBL] [Abstract][Full Text] [Related]
24. Differential effects of interleukin-15 and interleukin-2 on differentiation of bipotential T/natural killer progenitor cells.
Leclercq G; Debacker V; de Smedt M; Plum J
J Exp Med; 1996 Aug; 184(2):325-36. PubMed ID: 8760786
[TBL] [Abstract][Full Text] [Related]
25. Uncoupling IL-2 signals that regulate T cell proliferation, survival, and Fas-mediated activation-induced cell death.
Van Parijs L; Refaeli Y; Lord JD; Nelson BH; Abbas AK; Baltimore D
Immunity; 1999 Sep; 11(3):281-8. PubMed ID: 10514006
[TBL] [Abstract][Full Text] [Related]
26. Interleukin (IL)-15 induces survival and proliferation of the growth factor-dependent acute myeloid leukemia M-07e through the IL-2 receptor beta/gamma.
Meazza R; Basso S; Gaggero A; Detotero D; Trentin L; Pereno R; Azzarone B; Ferrini S
Int J Cancer; 1998 Oct; 78(2):189-95. PubMed ID: 9754651
[TBL] [Abstract][Full Text] [Related]
27. Interleukin-2, interleukin-15, and their receptors.
Waldmann T; Tagaya Y; Bamford R
Int Rev Immunol; 1998; 16(3-4):205-26. PubMed ID: 9505189
[TBL] [Abstract][Full Text] [Related]
28. Suppressor of cytokine signaling 1 regulates IL-15 receptor signaling in CD8+CD44high memory T lymphocytes.
Ilangumaran S; Ramanathan S; La Rose J; Poussier P; Rottapel R
J Immunol; 2003 Sep; 171(5):2435-45. PubMed ID: 12928391
[TBL] [Abstract][Full Text] [Related]
29. Differential localization of IL-2- and -15 receptor chains in membrane rafts of human T cells.
Goebel J; Forrest K; Morford L; Roszman TL
J Leukoc Biol; 2002 Jul; 72(1):199-206. PubMed ID: 12101281
[TBL] [Abstract][Full Text] [Related]
30. Lack of intermediate-affinity interleukin-2 receptor in mice leads to dependence on interleukin-2 receptor alpha, beta and gamma chain expression for T cell growth.
Chastagner P; Moreau JL; Jacques Y; Tanaka T; Miyasaka M; Kondo M; Sugamura K; Thèze J
Eur J Immunol; 1996 Jan; 26(1):201-6. PubMed ID: 8566067
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis.
Lenardo MJ
Nature; 1991 Oct; 353(6347):858-61. PubMed ID: 1944559
[TBL] [Abstract][Full Text] [Related]
32. Pharmacodynamic analysis of tofacitinib and basiliximab in kidney allograft recipients.
Vafadari R; Quaedackers ME; Kho MM; Mol WM; Chan G; Weimar W; Baan CC
Transplantation; 2012 Sep; 94(5):465-72. PubMed ID: 22960764
[TBL] [Abstract][Full Text] [Related]
33. Interleukin-15 triggers activation and growth of the CD8 T-cell pool in extravascular tissues of patients with acquired immunodeficiency syndrome.
Agostini C; Trentin L; Sancetta R; Facco M; Tassinari C; Cerutti A; Bortolin M; Milani A; Siviero M; Zambello R; Semenzato G
Blood; 1997 Aug; 90(3):1115-23. PubMed ID: 9242543
[TBL] [Abstract][Full Text] [Related]
34. Simultaneous dissection and comparison of IL-2 and IL-15 signaling pathways by global quantitative phosphoproteomics.
Osinalde N; Sanchez-Quiles V; Akimov V; Guerra B; Blagoev B; Kratchmarova I
Proteomics; 2015 Jan; 15(2-3):520-31. PubMed ID: 25142963
[TBL] [Abstract][Full Text] [Related]
35. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
Chen HW; Liao CH; Ying C; Chang CJ; Lin CM
Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844
[TBL] [Abstract][Full Text] [Related]
36. Defective IL-2-mediated IL-2 receptor alpha chain expression in Stat3-deficient T lymphocytes.
Akaishi H; Takeda K; Kaisho T; Shineha R; Satomi S; Takeda J; Akira S
Int Immunol; 1998 Nov; 10(11):1747-51. PubMed ID: 9846704
[TBL] [Abstract][Full Text] [Related]
37. Curcumin blocks interleukin (IL)-2 signaling in T-lymphocytes by inhibiting IL-2 synthesis, CD25 expression, and IL-2 receptor signaling.
Forward NA; Conrad DM; Power Coombs MR; Doucette CD; Furlong SJ; Lin TJ; Hoskin DW
Biochem Biophys Res Commun; 2011 Apr; 407(4):801-6. PubMed ID: 21443863
[TBL] [Abstract][Full Text] [Related]
38. TGF-beta inhibits IL-2-induced tyrosine phosphorylation and activation of Jak-1 and Stat 5 in T lymphocytes.
Bright JJ; Kerr LD; Sriram S
J Immunol; 1997 Jul; 159(1):175-83. PubMed ID: 9200453
[TBL] [Abstract][Full Text] [Related]
39. A potential role for interleukin-15 in the regulation of human natural killer cell survival.
Carson WE; Fehniger TA; Haldar S; Eckhert K; Lindemann MJ; Lai CF; Croce CM; Baumann H; Caligiuri MA
J Clin Invest; 1997 Mar; 99(5):937-43. PubMed ID: 9062351
[TBL] [Abstract][Full Text] [Related]
40. Lymphokine regulation of activation-induced apoptosis in T cells of IL-2 and IL-2R beta knockout mice.
Kung JT; Beller D; Ju ST
Cell Immunol; 1998 May; 185(2):158-63. PubMed ID: 9636694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
